Shingles Vaccine Recommended for Immunocompromised People

January, 2022 As of January, 2022, the U.S. Centers for Disease Control and Prevention (CDC) recommends the use of the vaccine Shingrix to prevent shingles and its complications in adults 19 years and older whose immune systems are weakened in addition to those adults 50 years and older whose immune systems are not compromised.  Shingrix […] Read More